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Abstract
Background Prehabilitation aims to improve post-operative outcomes by enhancing pre-operative fitness but is labour-
intensive. This pilot study aimed to assess the efficacy of a tri-modal prehabilitation programme delivered by smartwatches 
for improving functional fitness prior to major abdominal cancer surgery.
Methods A single-centre, randomised controlled pilot study, in which 22 patients were randomised to: (a) a prehabilitation 
group (n = 11), comprising of home-based exercise, nutritional, and dietary advice delivered using a wrist-worn smartwatch 
connected to a smartphone application; or (b) a control group (n = 11) receiving usual care, with patients given a smartwatch 
as a placebo. Eligible participants had over two weeks until planned surgery. The primary outcome was pre-operative physi-
cal activity including 6-min walk test (6MWT) distance, with secondary outcomes including change in body weight and 
hospital anxiety and depression score (HADS).
Results Recruitment was 67% of eligible patients, with groups matched for baseline characteristics. The prehabilitation 
group engaged in more daily minutes of moderate [25.1 min (95% CI 9.79–40.44) vs 13.1 min (95% CI 5.97–20.31), 
p = 0.063] and vigorous physical activity [36.1 min (95% CI 21.24–50.90) vs 17.5 min (95% CI 5.18–29.73), p = 0.022] 
compared to controls. They also had significantly greater improvements in 6MWT distance compared to controls [+ 85.6 m 
(95% CI, + 18.06 to + 153.21) vs + 13.23 m (95% CI − 6.78 to 33.23), p = 0.014]. HADS scores remained unchanged from 
baseline in both groups.
Conclusion Prehabilitation in the colorectal cancer care setting can be delivered using smartwatches and mobile applica-
tions. Furthermore, this study provides early indicative evidence that such technologies can improve functional capacity 
prior to surgery
Trial registration NCT04047524.
Keywords Exercise · Fitness trackers · Prehabilitation · Pre-operative · Smartwatches · Wearables
In the UK, patients undergoing major colorectal cancer 
surgery have 3% 90-day mortality and an 11% unplanned 
readmission rate from post-operative complications [1]. 
Tri-modal prehabilitation aims to enhance post-operative 
recovery by improving patients’ pre-operative functional 
capacity, nutritional status and psychological readiness for 
surgery via exercise, dietary, and psychological support 
[2]. Delivery of prehabilitation before major abdominal 
cancer surgery has ranged from unsupervised home-based 
interventions (exercise booklets, and CDs) and computer 
programs, to supervised hospital-based programmes using 
cycle ergometers and exercise equipment [3, 4]. Unsuper-
vised home-based programmes are less labour-intensive and 
more cost-effective but are reported to have lower compli-
ance rates (16–87%) [4, 5].
The impact of prehabilitation on functional capacity can 
be assessed using the 6-min walk test (6MWT) [6]. A clini-
cally meaningful increase in 6MWT distance is reported to 
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be 20 m [7–9] following 3–6 weeks of home-based preha-
bilitation [10, 11]. A recent pooled analysis of comparative 
studies suggests this may result a 5-year disease free survival 
in stage III colorectal cancer patients from 50.9% without 
prehabilitation versus 73.4% with (p = 0.044) [12]. Deliv-
ery of prehabilitation across a healthcare system however, 
remains a challenge [13]. Wearable technologies linked to 
smartphones through software applications can promote 
health behaviour change including physical activity, reha-
bilitation, weight loss, and may be ideally suited to deliv-
ering prehabilitation [14–16]. This prospective randomised 
controlled pilot study aimed to determine whether tri-modal 
prehabilitation delivered via a wearable technology can suc-
cessfully increase pre-operative physical activity levels and 
improve pre-operative functional capacity in patients under-
going major abdominal cancer surgery.
Materials and methods
This was a single-centre, parallel-arm randomised controlled 
pilot study (NCT04047524). During the study period con-
secutive patients undergoing major abdominal cancer sur-
gery at a tertiary cancer centre (The Christie NHS Foun-
dation Trust, Manchester, UK) were randomised (1:1) to 
the intervention or control group. A sample size of 15 in 
each group was calculated based on the ability to detect an 
increase in the primary outcome 6MWT distance of 20 m in 
the prehabilitation versus the standard care group. The inter-
vention group received a prehabilitation programme deliv-
ered using a Fitbit Smartwatch (Fitbit Inc, San Francisco, 
CA, USA) with a digital display and Smartphone Applica-
tion (App). The control group received a Fitbit smartwatch 
with no display or patient feedback as a placebo. This meant 
comparable activity data was collected in both groups. Clini-
cal aspects of care were not altered for either group. The 
study was approved by Health and Social Care REC A on 
25/02/2019 and Health Research Authority on 05/03/2019. 
Written informed consent was obtained from all participants 
prior to enrolment.
Inclusion criteria
Participants had to be aged 18 years or over, able to consent 
to participate in the prehabilitation programme, be undergo-
ing major abdominal cancer surgery, have at least 2 weeks to 
their operation date, and be able to understand written and 
spoken English.
Exclusion criteria
Participants were excluded if they had any health condi-
tions which prevented them from safely taking part in a 
home-based exercise programme. These included patients 
who had within the past 3 months had a myocardial infarc-
tion or stroke. Participants were also excluded if they were 
already active users of an activity monitoring smartwatch. 
Patients were not excluded if they were already completing 
the UK national recommendation of 150 min physical activ-
ity per week [17] to avoid selection bias.
Randomisation
A random sequence with 15 participants in each study 
group was generated using the online randomisation soft-
ware “GraphPad” (GraphPad Software Inc, San Diego, CA, 
USA). This sequence was placed into sequentially numbered 
sealed opaque envelopes. After participants gave their fully 
informed consent and completed baseline questionnaires 
and observations, the appropriate sequential envelope was 
opened to obtain group allocation. All participants then 
completed baseline 6MWT.
Blinding
All patients approached were informed that the study was 
investigating whether prehabilitation could have a role 
to play in improving pre-operative fitness. It was clearly 
explained that allocation to the control or prehabilitation arm 
of the study would not knowingly advantage or disadvantage 
them in any way. Whilst both groups were given wearable 
devices (placebo in the control group as outlined below), the 
inherent differences between the intervention and control 
groups made blinding challenging for study participants. The 
baseline 6MWT distance was used by the physiotherapist to 
determine baseline fitness in the prehabilitation group par-
ticipants in order to help tailor the intensity of their physical 
activity.
Wearable activity monitors
A Fitbit Charge 2 smartwatch was provided to each par-
ticipant in the prehabilitation group. This has a screen that 
allows the wearer to self-monitor real-time physical activ-
ity levels. A Fitbit Flex 2 (placebo device) was provided to 
each participant in the control group. This is a band without 
a screen that can be set to not provide feedback on physical 
activity levels to the wearer. Both smartwatches record daily 
steps and duration and intensity of physical activity, which 
can be viewed via the Fitbit App (https:// www. fitbit. com), 
which was downloaded onto participants’ smartphones 
(participants without a smartphone were loaned one). All 
participants were instructed to wear their device all days of 
the pre-operative period and received instructions on how to 
upload smartwatch data to the Fitbit App daily using Blue-
tooth wireless technology. In the control group the App was 
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only used to collect data from their Fitbit with no feedback 
given. Data from the control group were used as an objec-
tive measure of daily physical activity levels in a sample of 
patients not provided with a prehabilitation programme, for 
comparison with the same data from the intervention group.
Tri‑modal prehabilitation group intervention
Prehabilitation group participants were shown how to use 
the Fitbit Charge 2 device and Fitbit App as a motivational 
tool for increasing daily physical activity levels and were 
shown how to use the Fitbit App food log to support dietary 
behaviour change. A separate mindfulness app was provided 
for stress management. Standardised structured weekly 
phone calls were provided to allow reporting of technical 
issues and provide tailored prehabilitation support.
Structured exercise and physical activity
Participants in the prehabilitation group were assessed by 
a physiotherapist and given an individualised structured 
exercise and physical activity programme. This comprised 
aerobic exercise (3 × per week), resistance exercise using a 
resistance band consisting of 8–10 repetitions in two sets 
(2 × per week), and encouragement to engage in additional 
physical activity (e.g. increasing daily walking, use of stairs, 
etc.) or structured exercise of their choice for 30 min on two 
other days. The intensity of activity was tailored to each 
participant’s individual fitness level, as shown in Fig. 1, with 
the physiotherapist also assessing baseline strength and pro-
viding a resistance band of appropriate resistance. Each par-
ticipant’s target heart rate was calculated using the Karvonen 
formula and participants were instructed to aim for this tar-
get heart rate during the prescribed exercise using the heart 
rate monitor on the Fitbit Charge 2. Participants were con-
sidered to be completing moderate-intensity activity when 
achieving 50–70% of their predicted maximum heart rate 
(based on 220—age) [18]. Participants were also provided 
with a BORG Perceived Exertion Scale and instructed to 
work at a level of perceived exertion between 12 and 16 
indicating “somewhat hard” to “hard” physical activity.
Nutrition
Increased protein intake through Oral Nutritional Supple-
mentation has been demonstrated to reduce length of stay 
by 2 days following colorectal surgery [19] and poor pre-
operative nutritional status in cancer patients is associated 
with sarcopenia and myopenia which increase post-opera-
tive complications [20, 21]. Therefore, participants in the 
Fig. 1  The intensity of exercise 




prehabilitation group were provided with written dietary 
advice and watched a presentation on pre-operative nutrition 
which emphasised the importance of avoiding unintentional 
weight loss and increasing protein consumption to maintain 
muscle mass prior to surgery. This advice is presented in 
Online Appendix. They were shown how to use the Fitbit 
App food log and encouraged to use this to monitor their 
daily dietary intake and increase protein intake.
Psychosocial support
The peri-operative period is associated with increased levels 
of anxiety and depression in cancer patients [22, 23]. Pre-
operative psychological support may relieve these symptoms 
and improve Quality of Life for patients awaiting cancer 
surgery and mindfulness apps have previously been shown 
to reduce symptoms of anxiety and depression in cancer 
patients [24, 25]. Participants in the prehabilitation group 
were therefore instructed to complete one guided medita-
tion per day using a mindfulness app which provides stress 
management and relaxation techniques (Smiling Mind Pty 
Ltd—https:// www. smili ngmind. com. au/ smili ng- mind- app).
Outcome measures
The primary outcome was quantitative data collected via 
a Fitbit aimed at determining the number of participants 
whose physical activity increased and by how much during 
the study. This included levels of physical activity (light, 
moderate, and vigorous) and functional walking capacity 
as measured by the 6MWT which was conducted according 
to standard operating procedures at baseline and on the day 
before surgery [6]. Secondary outcomes included: change in 
body weight, and change in psychological well-being meas-
ured using the Hospital Anxiety and Depression (HADS) 
questionnaire from baseline to the day before surgery, daily 
step counts, and participant satisfaction [26]. Daily step 
counts were determined by the smartwatch accelerometers 
and active minutes were calculated using estimates of meta-
bolic equivalents after 10 continuous minutes of physical 
activity. Patient recruitment and retention rates and adverse 
events were also recorded.
Both the Fitbit Flex 2 and Charge 2 use the same 3-axis 
accelerometer technology to record activity levels and Fitbit 
devices have previously demonstrated accuracy and inter-
device reliability [27, 28]. Physical activity data were syn-
chronised to an online study dashboard “Fitabase” (Fitabase, 
San Diego, CA, USA) which allowed the research team to 
perform retrospective analysis. An Information Govern-
ance officer thoroughly reviewed the Fitabase privacy notice 
(Available from: www. fitab ase. com/ resou rces/ knowl edge- 
base/ worki ng- with- the- irb/ data- secur ity- priva cy/) to ensure 
compliance to data security and ethical guidelines and had 
no concerns relating to the security of the de-identified data. 
Fitabase is under the Privacy shield framework, and they do 
not collect IP addresses or GPS data.
Statistical analysis
Data analysis was undertaken using StatsDirect (StatsDirect 
Ltd, Merseyside, UK). Statistical significance was defined as 
a p value of < 0.05. A Shapiro–Wilk test was used to deter-
mine whether data were normally distributed. Normally dis-
tributed data were compared using an independent groups 
t test. Non-normally distributed data were compared using 
a Mann–Whitney U test. Within-group analyses were con-
ducted using a paired T test. Qualitative data was generated 
from end-of-study questionnaires.
Results
This study was open to recruitment between 14/05/2019 
and 23/09/2019. A total of 33 participants were identified, 
of which 11 were either declined or were ineligible, leav-
ing 22 participants randomised during the enrolment period 
(Fig. 2). The overall recruitment rate was 67% (rising to 
79% when excluding patients who did not meet the inclu-
sion criteria). Of note, no patient was excluded because of 
pre-existing medical conditions. Retention on the study was 
100%.
Baseline characteristics
Baseline characteristics of the prehabilitation and control 
groups are reported in Table 1. The mean duration from 
enrolment to the day before surgery was greater in the preha-
bilitation group at 30.5 (95% CI 18.7–42.2) days versus 20.8 
(95% CI, 12.7–29.0) days in the control group (p = 0.072), 
although this was not statistically significant. This difference 
in days before surgery between the two groups occurred as 
two prehabilitation group participants had their scheduled 
surgery date unexpectedly delayed following enrolment. 
There was no significant difference between the two groups 
for baseline 6MWT distance or HADS (Table 2).
Patient compliance
Prehabilitation group participants wore the Fitbit Charge 2 
on 98.9% of days and control group participants wore the 
placebo Fitbit Flex 2 on 95.8% of days between enrolment 
and surgery. Compliance with the exercise component was 
high, with prehabilitation group participants achieving 
30 min of moderate-intensity activity on average 59.9% 
(95% CI, 41.3–78.5) of the days during the pre-operative 
period, compared to 42.6% (95% CI 18.4–66.7) of days in 
Surgical Endoscopy 
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Fig. 2  CONSORT flow diagram 
of participants through the study
Table 1  Baseline characteristics 
and surgical details of the 
prehabilitation and control 
groups
Data are expressed as mean (95% CI), n (%), or male:female
AP abdominoperineal, BMI body mass index, CRS with HIPEC cytoreductive surgery and hyperthermic 
intraperitoneal chemotherapy, ECOG Eastern Cooperative Group
Prehabilitation group 
(n = 11)
Control group (n = 11) p value
Age (years) 55.5 (49.2, 61.7) 61.0 (53.1, 68.9) 0.223
Age ≥ 65 years 1 (9%) 4 (36%)
Sex ratio (male:female) 4:7 7:4
BMI (kg/m2) 30.0 (25.6, 34.4) 27.8 (23.4, 32.2) 0.442
ECOG performance status
 0 9 (82%) 10 (91%)
 1 2 (18%) 1 (9%)
 2–4 0 (0%) 0 (0%)
Primary diagnosis
 Colorectal adenocarcinoma 7 (64%) 8 (73%)
 Pseudomyxoma peritonei 3 (27%) 1 (9%)
 Other 1 (9%) 2 (18%)
Type of surgery
 CRS and HIPEC 9 (82%) 7 (64%)
 AP resection 0 (0%) 2 (18%)
 Total pelvic clearance 1 (9%) 1 (9%)
 Right hemicolectomy + cystectomy 0 (0%) 1 (9%)
 Laparotomy + small bowel resection 1 (9%) 0 (0%)
Length of time from study appointment to 
surgery (days)
30.5 (18.7, 42.2) 20.8 (12.7, 29.0) 0.072
 Surgical Endoscopy
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the control group. As prehabilitation group participants were 
encouraged to engage in 30 min moderate-vigorous activity 
on at least 5 days a week, we can infer that compliance to 
the programme was 84% (i.e. 4.2 days). Comparatively if we 
apply the same criterion to the control group, “compliance” 
was 60% (i.e. 3.0 days). Compliance to resistance training 
component could not be objectively monitored via the Fitbit.
Usability of the Fitbit food log was also high, with pre-
habilitation group participants logging food on average 
82.9% of the days. Participants on average only listened 
to the mindfulness App on 15% of days. Reasons for non-
compliance to the mindfulness intervention included par-
ticipants reporting good baseline mental health, finding the 
App unhelpful, and only using the App when they felt they 
needed to. Most participants (73%) already owned a suitable 
smartphone or tablet and the other 27% (six participants) 
were loaned a smartphone due to incompatibility of their 
own device with the FitBit, connection issues, or not owning 
a smartphone. One technical issue was reported during the 
study (a Fitbit Flex 2, which stopped charging). No adverse 
events were reported.
Physical activity levels
Average daily minutes of vigorous intensity activity were 
significantly greater in the prehabilitation group [36.1 min 
(95% CI 21.2–50.9 min) vs 17.5 min (95% CI 5.2–29.7 min), 
p = 0.022]. Daily minutes of moderate-intensity activity 
were also higher in the prehabilitation group compared 
to the control group [25.1 min (95% CI 9.8–40.4 min) vs 
13.1 min (95% CI 6.0–20.3 min), p = 0.063], although these 
results did not reach statistical significance. Daily minutes 
of light intensity activity were similar between the groups 
[208.3 min (95% CI 170.2–246.5 min) vs 205.3 min (95% 
CI 146.1–264.5 min), p = 0.925]. Mean daily step counts 
during the prehabilitation period were greater in the preha-
bilitation group compared to control group [8919 (95% CI 
7024–10814) versus 7961 (95% CI 5314–10608), p = 0.519], 
although this was not statistically significant.
Functional capacity
Table 2 presents the 6MWT distance at baseline and on the 
day before surgery for both study groups. The mean change 
in 6MWT distance for the prehabilitation group during the 
pre-operative period was + 85.6 m (95% CI 18.1–153.2 m) 
compared to + 13.2 m (95% CI − 6.8 to 33.2 m) in the con-
trol group (p = 0.014). All participants in the prehabilitation 
group improved their 6MWT distance, with nine participants 
(82%) increasing by 20 m or more. In the control group, 
eight participants increased their 6MWT distance, with only 
three (27%) participants improving by more than 20 m. In 
addition, three control group participants (27%) declined in 
6MWT performance, with one participant (9%) declining 
by greater than 20 m.
Body weight
Changes in body weight during the pre-operative period 
were minimal for both study groups. Mean change in weight 
in the prehabilitation group was + 0.46 kg (range − 1.0 
to + 2.5 kg) versus − 1.06 kg (range − 3.85 to + 0.70 kg) 
in the control group. Qualitative analysis of the nutritional 
intervention identified that all prehabilitation participants 
used the food log on most days. Participants stated that the 
food log “gave me increased focus on my calorie control” 
and “helped to increase my food intake, but protein targets 
were difficult to stick to”, although two participants stated 
the app-based food diary was confusing and difficult to use.
Table 2  Mean baseline HADS 
Scores and change in mean 
6-min walk test distance from 
baseline until the day before 
surgery (pre-operative)
Data are presented as mean (95% CI) or n (%)
6MWT 6-min walk test, HADS hospital anxiety and depression scale
a “No change” represents participants whose pre-operative 6MWT distance was within ± 20 m of their base-
line 6MWT distance
Outcome measure Prehabilitation group (n = 11) Control group (n = 11) p value
Baseline HADS anxiety score 5.8 (3.7, 10.1) 6.6 (3.2, 10.1) 0.658
Baseline HADS depression score 3.1 (1.4, 4.8) 3.7 (1.5, 6.0) 0.622
Baseline 6MWT (metres) 520.9 (450.4, 591.3) 482.6 (433.3, 532.0) 0.156
Pre-operative 6MWT (metres) 606.5 (528.7, 684.3) 495.9 (454.3, 537.4) 0.011
Mean change in 6MWT during pre-
operative period (metres)
+ 85.6 (+ 18.1, + 153.2) + 13.2 (− 6.8, 33.2) 0.0135
Change in 6MWT during pre-operative period
 Improvement 9 (82%) 3 (27%)
 No  changea 2 (18%) 7 (64%)




Mean HADS Anxiety Scale scores decreased slightly in both 
the prehabilitation and control groups. No significant differ-
ence in the reduction of HADS anxiety scores between the 
prehabilitation and control groups was found [− 0.5 (95% 
CI − 2.0 to + 0.9) versus − 1.2 (95% CI − 2.1 to − 0.2) 
respectively, p = 0.415]. Mean HADS Depression scores also 
decreased slightly in both the prehabilitation and control 
groups [− 1.4 (95% CI − 2.4 to − 0.3) vs − 0.8 (95% CI 
− 2.2 to + 0.5) respectively, p = 0.484]. Within-group analy-
sis identified that the reduction in HADS Anxiety and HADS 
Depression scores were not significant in either group.
Participant satisfaction
Following completion of the prehabilitation programme, 
participants completed an end-of-study questionnaire. 
Responses to this questionnaire are presented in Table 3. 
Overall, 100% of participants rated both the prehabilitation 
programme overall and the exercise component “Good” or 
“Excellent”. Ten participants (90%) responded “Strongly 
Agree” or “Agree” to the statement “The Fitbit motivated 
me to do the physical activity that was part of the prehabili-
tation programme”.
In addition, participants in the control group were asked 
“The Fitbit motivated me to increase my physical activ-
ity although I was not asked to complete an exercise pro-
gramme”, to which five (45%) participants stated they 
“Strongly Agree” and four (36%) participants stated they 
“Agree”, with two (18%) responding “Neutral”.
Discussion
Prehabilitation aims to improve pre-operative functional 
capacity and “cardiopulmonary reserve” through pre-
operative exercise, nutritional optimisation, and enhanc-
ing psychological readiness for surgery. The results of 
this study suggest that a programme of remotely sup-
ported tri-modal prehabilitation may increase pre-oper-
ative functional capacity before major abdominal cancer 
surgery. Smartwatches and associated technologies were 
used as the mainstay support for a prescribed programme 
of structured exercise/physical activity, optimal nutrition, 
and stress management. Participants allocated to preha-
bilitation increased their pre-operative 6MWT distance 
by an average of 85.6 m, with nine participants achieving 
an increase of > 20 m, suggesting a clinically important 
improvement in functional capacity. A previous RCT has 
demonstrated marginally greater increases in 6MWT dis-
tance in an exercise prehabilitation group compared to a 
control group (+ 31 m vs + 27 m) following home-based 
prehabilitation; however, this study required a physical 
therapist to make regular home visits (on six occasions 
over 4 weeks) to ensure compliance to the exercise pro-
gramme [29]. Conversely, Carli and colleagues found 
a reduction in 6MWT distance in a bike/strengthening 
group (− 6.8 m) following home-based prehabilitation 
Table 3  Prehabilitation group participant’s responses to the End-of-Study Questionnaire
Data are presented as n (%)
Item Agreement rating
Excellent Good Average Fair Poor Not answered
How would you rate the prehabilitation programme overall? 5 (45%) 6 (55%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
How would you rate the exercise component of the prehabili-
tation programme?
5 (45%) 6 (55%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
How would you rate the dietary component of the prehabilita-
tion programme?
3 (27%) 5 (45%) 3 (27%) 0 (0%) 0 (0%) 0 (0%)
How would you rate the mental well-being component of the 
prehabilitation programme?
3 (27%) 3 (27%) 2 (18%) 0 (0%) 1 (9%) 2 (18%)
Strongly agree Agree Neutral Disagree Strongly disagree Not answered
The Fitbit Charge 2 was easy to use 9 (81%) 0 (0%) 1 (9%) 0 (0%) 0 (0%) 1 (9%)
The Fitbit Charge 2 was comfortable to wear 10 (90%) 1 (9%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
The Fitbit motivated me to do the physical activity that was 
part of the prehabilitation programme
5 (45%) 5 (45%) 1 (9%) 0 (0%) 0 (0%) 0 (0%)
The tailored exercise regime helped me to increase my exer-
cise levels
5 (45%) 6 (55%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Taking part in this programme has encouraged me to increase 
the amount of exercise I do once I recover from surgery
8 (72%) 2 (18%) 1 (9%) 0 (0%) 0 (0%) 0 (0%)
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and compliance rate of only 16% despite home visits and 
weekly phone calls [5]. Our study has demonstrated that 
functional walking capacity may be increased to a desired 
threshold with prehabilitation delivered through a wear-
able technology and smartphone application. The accept-
ability and compliance with this device and its associ-
ated exercise intervention was high with patients reaching 
30 min moderate-intensity activity on 84% of days they 
were encouraged to do so. This compares to compliance 
rates of 16–87% in previously reported pilot studies of 
home-based prehabilitation [4].
Daily activity levels were higher in the prehabilitation 
compared to the control group, with the latter completing 
significantly more minutes of vigorous daily exercise and 
increased minutes of moderate daily exercise. Feedback 
from end-of-study questionnaire suggests that the Fitbit 
wearable devices were an independent factor responsible 
for encouraging participants to complete the prescribed 
exercise by providing easily visible feedback on progress 
towards activity goals.
The nutritional intervention aimed to prevent uninten-
tional weight loss prior to surgery which is particularly 
important in cancer patients. The relatively high baseline 
BMI of our groups (27–30 kg/m2) reflects the nutritional 
and body mass status of patients in our UK population, 
although it should be noted that BMI is itself a crude 
measure of nutrition. One of the limitations of prehabili-
tation before cancer surgery is there are not more than 
2–3 weeks in which to deliver a nutritional intervention. 
Changes in body weight from baseline to the day before 
surgery were minimal in both groups but this interven-
tion may be more relevant for frailer patients to prevent 
further weight loss before surgery and warrants further 
review. Qualitative comments suggest that the protein tar-
gets were challenging for patients, suggesting the use of 
a food log App may need further development to improve 
efficacy in this setting. Oral Nutritional Supplementation 
has previously been shown to reduce post-operative length 
of stay following colorectal surgery [19] and could be used 
alongside dietary advice in frailer patients to enhance the 
dietary component of our prehabilitation programme. The 
incorporation of a nutritional status questionnaire, such as 
the Nutrition Risk Screening Tool 2002 [30], into baseline 
assessments could identify those patients at greatest risk 
for weight loss and malnutrition and ONS could be pro-
vided to these at-risk patients.
The psychological intervention aimed to reduce pre-
operative stress and anxiety by teaching mindfulness stress 
management techniques. In-group analysis revealed that 
reductions in anxiety and depression in the prehabilitation 
group were not statistically significant. This may reflect 
poor compliance with the psychological intervention 
or poor efficacy of the mindfulness app in this context, 
suggesting further development of the mindfulness com-
ponent may also be needed.
Several limitations of this pilot study should be noted. 
Firstly, participants could not be completely blinded to 
their allocated study group. This may have generated bias 
as participants in the control group were aware that we 
were investigating the impact of pre-operative exercise and 
may have altered their exercise levels accordingly. The 
control group were provided with a placebo Fitbit Flex 
2 (no display screen or feedback), with our end-of-study 
questionnaire suggesting 82% of control group participants 
stated that they increased physical activity just because 
they were given a placebo device to wear. This demon-
strates how even just wearing a smartwatch can increase 
motivation for physical activity. It is important to note that 
we did not exclude patients who were already completing 
the national recommendation of 150 min physical activity 
per week, but even these patients reported enjoying par-
ticipation and that it “gave them something to focus on”, 
with a beneficial effect on their mental health. Finally the 
sample size in this study was small with a risk of Type 2 
error.
To our knowledge, this is the first pilot study to demon-
strate the efficacy of delivering home-based prehabilitation 
prior to major abdominal cancer surgery using wearable 
smart technologies, with clinically and statistically signifi-
cant improvements in functional walking capacity and higher 
levels of vigorous physical activity in the prehabilitation 
group when compared to controls. This study has demon-
strated that the delivery of home-based prehabilitation using 
smartwatches and mobile applications is well-accepted in 
patients awaiting major abdominal cancer surgery, and that 
the primary outcomes of 6-min walk test (6MWT) distance 
and levels of activity as measured by wearable devices may 
be reliably used in future trials. We feel that further optimi-
sation of the nutritional and psychological components is 
required, perhaps through further integration into a single 
smartphone application. A fully powered RCT is warranted 
to investigate the effects of a prehabilitation programme on 
post-operative outcome measures such as length of hospital 
stay and complication rates in this setting.
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